Scientists map high-risk areas for hepatitis E

EPFL scientists have created the first world map of regions with the highest prevalence of the hepatitis E virus (HEV). They hope that their map—freely available online—will help governments and NGOs design more effective prevention campaigns based on reliable data, particularly when it comes to setting up refugee camps. The scientists’ research has just been published in Scientific Reports. In […]

Continue reading »

New therapy approach points to potential treatment of liver cancer patients with hepatitis B virus infection

Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found in the body, to treat Hepatocellular carcinoma (HCC), a commonly occurring liver cancer. The treatment was also individualised, as T cells that were engineered were specific to the patients. The approach […]

Continue reading »

Hepatitis B

Hepatitis B virus (HBV) infects the liver. There’s a very effective vaccine that prevents HBV infection. The vaccine is usually given to babies, but some teens, especially those from other countries may have not received the vaccine. Check with your health care provider to make sure you’ve received all of your shots. Who gets Hepatitis B? Anyone can get Hepatitis […]

Continue reading »

Canada updates guidelines for hepatitis C virus infection

(HealthDay)—A guideline published in the June 4 issue of CMAJ, the journal of the Canadian Medical Association, provides updated evidence-based recommendations for the treatment of patients with chronic hepatitis C virus (HCV) infection. Hemant Shah, M.D., from the University of Toronto, and colleagues conducted a focused literature search to update the evidence base used in the 2015 guideline. The resulting […]

Continue reading »

Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

Transplanting hepatitis C (HCV)-infected dialysis patients with organs from HCV-positive donors and then treating the infection after transplantation is more effective, costs less and will shorten wait times for donated organs, according to a computer analysis conducted by physician-researchers at the University of Cincinnati (UC) College of Medicine. The findings are available online in the Annals of Internal Medicine. The […]

Continue reading »

Insurance denials for new hepatitis C drugs remain high nationwide, study suggests

Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the U.S. in 2014. But both public and private insurers continue to deny coverage for these costly drugs at high rates nationwide, despite efforts to remove treatment restrictions, according to a new study published in Open Forum Infectious Diseases. The […]

Continue reading »

Infants exposed to hepatitis C increasing, yet not adequately screened, study finds

Due to the opioid epidemic, hepatitis C virus (HCV) is increasingamong pregnant women, resulting in a greater risk of perinatal transmission and HCV infection among children. Despite this increased prevalence, HCV-exposed infants are not adequately screened and many pediatric HCV infections remain undetected, according to a new study from researchers at Magee-Womens Research Institute (MWRI). The results are reported in […]

Continue reading »
1 2